Regeneron Pharmaceuticals Currently Down Seven Consecutive Days, on Track for Longest Losing Streak Since October 2018 -- Data Talk
15 Novembro 2023 - 1:29PM
Dow Jones News
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $792.61,
down $1.09 or 0.14%
--Would be lowest close since Nov. 1, 2023, when it closed at
$791.27
--Currently down eight of the past nine days
--Currently down seven consecutive days; down 4.78% over this
period
--Longest losing streak since Oct. 26, 2018, when it fell for
seven straight trading days
--Worst seven day stretch since the seven days ending Oct. 27,
2023, when it fell 6.16%
--Up 1.63% month-to-date
--Up 9.86% year-to-date
--Down 6.13% from its all-time closing high of $844.37 on Aug.
21, 2023
--Up 7.74% from 52 weeks ago (Nov. 16, 2022), when it closed at
$735.67
--Down 6.13% from its 52-week closing high of $844.37 on Aug.
21, 2023
--Up 16.48% from its 52-week closing low of $680.49 on Jan. 9,
2023
--Traded as low as $784.96
--Down 1.1% at today's intraday low
--10th least active stock in the Nasdaq 100 today
All data as of 10:56:12 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 15, 2023 11:14 ET (16:14 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024